Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery

Regional Anesthesia and Pain Medicine

Volumn 35, Issue 6, 2010, Pages 490-495

  Deegan, Catherine A ^a   Murray, David ^b   Doran, Peter ^b   Moriarty, Denis C ^c   Sessler, Daniel I ^d   Mascha, Ed ^d   Kavanagh, Brian P ^e   Buggy, Donal J ^c,f  

^a Department of Anesthesia and Intensive Care Medicine ^*  (United States)

^b UCD School of Medicine and Medical Sciences   (United States)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f National Cancer Screening Service   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPRIFUSOR; FENTANYL; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LEVOBUPIVACAINE; MORPHINE; PARACETAMOL; PROPOFOL; SEVOFLURANE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOCYTE COUNT; MASTECTOMY; PAIN ASSESSMENT; PARAVERTEBRAL ANESTHESIA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGIONAL ANESTHESIA; VISUAL ANALOG SCALE;

AGED; ANALGESICS, OPIOID; ANESTHESIA, CONDUCTION; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ANESTHETICS, LOCAL; BREAST NEOPLASMS; BUPIVACAINE; CYTOKINES; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKINS; IRELAND; MASTECTOMY; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; METHYL ETHERS; MIDDLE AGED; MORPHINE; NERVE BLOCK; PAIN, POSTOPERATIVE; PILOT PROJECTS; PROPOFOL; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78149252955     PISSN: 10987339     EISSN: None     Source Type: Journal    
DOI: 10.1097/AAP.0b013e3181ef4d05     Document Type: Article

References (36)

1. Bendre MS, Gaddy-Kurten D, Mon-Foote T, et al. Expression of interleukin 8 and not parathyroid hormoneYrelated protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res. 2002;62:5571-5579.
2. Eschwege P, Dumas F, Blanchet P, et al. Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet. 1995;346:1528-1530.
3. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1:149-153.
4. Tsuchiya Y, Sawada S, Yoshioka I, et al. Increased surgical stress promotes tumor metastasis. Surgery. 2003;133:547-555.
5. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol. 2003;10:972-992.
6. Little D, Regan M, Keane RM, Bouchier-Hayes D. Perioperative immune modulation. Surgery. 1993;114:87-91.
7. Antoni MH, Lutgendorf SK, Cole SW, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer. 2006;6:240-248.
8. Rao VS, Dyer CE, Jameel JK, Drew PJ, Greenman J. Potential prognostic and therapeutic roles for cytokines in breast cancer [review]. Oncol Rep. 2006;15:179-185.
9. Sacerdote P, Bianchi M, Gaspani L, et al. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg. 2000;90:1411-1414.
10. Shapiro J, Jersky J, Katzav S, Feldman M, Segal S. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest. 1981;68:678-685.
11. Beilin B, Shavit Y, Hart J, et al. Effects of anaesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg. 1996;82:492-497.
12. Shavit Y, Ben-Eliyahu S, Zeidel A, Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation. 2004;11:255-260.
13. Page GG, Blakely WP, Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain. 2001;90:191-199.
14. Bar-Yosef S, Melamed R, Page GG, Shakhar G, Shakhar K, Ben-Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology. 2001;94:1066-1073.
15. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 2006;4:660-664.
16. Biki B, Moriarty DC, Mascha E, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology. 2007;10:180-187.
17. Nicolini A, Carpi A, Rossi G. Cytokines in breast cancer. Cytokine Growth Factor Rev. 2006;17:325-337.
18. Eason MJ, Wyatt R. Paravertebral thoracic block: a reappraisal. Anaesthesia. 1979;34:638-642.
19. Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008;8:887-899.
20. Borish L, Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol. 2003;111:S460-S475.
21. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-867.
22. de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nature. 2006;6:24-37.
23. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007;121:2373-2380.
24. Ben-Baruch A. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol. 2006;16:38-52.
25. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumours to malignancy. J Exp Med. 2001;193:727-740.
26. Baniyash M. Chronic inflammation, immunosuppression and cancer: new insights and outlook. Semin Cancer Biol. 2006;16:80-88.
27. Jin L, Yuan RQ, Fuchs A, et al. Expression of interleukin-1beta in human breast carcinoma. Cancer. 1997;80:421-434.
28. Saijo Y, Tanaka M, Miki M, et al. Proinflammatory cytokine IL-1A promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J Immunol. 2002;169:469-475.
29. Shibata Y, Foster LA, Kurimoto M, et al. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gammaYinducing factors but enhances NK cell production of IFN-gamma. J Immunol. 1998;161:4283-4288.
30. Asadullah K, Sterry W, Volk HD. Interleukin-10 therapyVreview of a new approach. Pharmacol Rev. 2003;55:241-269.
31. Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2000;2:252-257.
32. Przybylowska K, Kluczna A, Zadrozny M, et al. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast Cancer Res Treat. 2006;95:65-72.
33. Lin CW, Shen SC, Hou WC, Yang LY, Chen YC. Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9. Mol Cancer Ther. 2008;7:1195-1206.
34. Herroeder S, Pecher S, Schönherr ME, et al. Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial. Ann Surg. 2007;246:192-200.
35. Galan M, Vinolas N, Colomer D, et al. Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation. Anticancer Res. 2002;22:2877-2884.
36. Langsenlehner U, Krippl P, Renner W, et al. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat. 2005;90:113-115.